Published Results Show Denosumab Superior To Zometa(R) In Delaying Or Preventing Bone Complications In Patients With Advanced Breast Cancer
Links shared publicly online about this topic.
- 737total visits
Published Results Show Denosumab Superior To Zometa(R) In Delaying Or Preventing Bone Complications In Patients With Advanced Breast Cancer
Amgen (Nasdaq: AMGN) announced the publication of results from a pivotal Phase 3 study of 2,046 patients which compared denosumab with Zometa(R) (zoledronic acid) in delaying or preventing skeleta
View full resource at medicalnewstoday.com
Tags: Breast Cancer, Metastatic Breast Cancer, Bone, Osteoporosis Medication, Women's Health, Prolia, Preventing
Most Recently Shared on November 10, 2010 at 9:05 pm By:
Published Results Show Denosumab Superior To Zometa(R) In Delaying Or Preventing Bone Complications In Patients With A... http://mnt.to/3Mm2
Also Shared By:
Denosumab superior to Zometa in delaying/preventing bone complications in advanced breast cancer patients -- data published today in Journal of Clinical Oncology - Drugs.com MedNews
drugs.com — “Published RESULTS SHOW Denosumab SUPERIOR TO ZOMETA in DELAYING OR PREVENTING Bone COMPLICATIONS in Patients WITH BONE METASTASES FROM Advanced Breast Cancer Bo” View full resource at drugs.com
Most Recently Shared on November 9, 2010 at 5:16 pm By:
Drugs and Devices OW OW Health
Denosumab superior to Zometa in delaying/preventing bone complications in advanced breast cancer patients ... http://bit.ly/dDc0AX #drug
Advertisement
MNT Bones/Orthopedic
@mnt_bones
Published Results Show Denosumab Superior To Zometa(R) In Delaying Or Preventing Bone Complications In Patients With A... http://mnt.to/3Mm2
1 year ago...